Viewing StudyNCT00000832



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000832
Status: COMPLETED
Last Update Posted: 2021-11-04
First Post: 1999-11-02

Brief Title: A Randomized Placebo-Controlled Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein HIV-1 SF-2 rgp120 BIOCINE Combined With MF59 in HIV-1 Uninfected Adult Volunteers
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
HIV Preventive Vaccine View
Vaccines Synthetic View
HIV-1 View
Adjuvants Immunologic View
HIV Envelope Protein gp120 View
AIDS Vaccines View
HIV Seronegativity View